Evaluation of Quality of Life in Women

June 29, 2020 updated by: Arzu Demircioğlu, Hacettepe University

Investigation of Affecting Factors Quality of Life in Women

300 women will be evaluated in this study. Their quality of life, level of physical activity, Social Functioning, levels of depression and musculoskeletal status will be assessed.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Many factors affects quality of life in women. In the literature, factors affecting the quality of life such as diseases, working conditions and psychological factors of women have been investigated in different diseases. However, there was no study investigating the factors affecting quality of life for a sample of adult female individuals. Therefore, the aim of our study is to investigate the effect of social, psychological and physical variables that we think may affect the quality of life in women.

Study Type

Interventional

Enrollment (Actual)

227

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
      • Ankara, Turkey, 06100
        • Hacettepe University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 60 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • To be a volunteer

Exclusion Criteria:

  • having severe musculoskeletal system disorders

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental Group: quality of life assessment
Women's quality of life will be evaluated.
Other: Quality of life assessment
Quality of life will be assessed with Nottingham Health Profile

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quality of life
Time Frame: 5 minutes
The Nottingham Health Profile is a general patient self-evaluation of subjective health status. The score of this questionnaire ranges between 0 and 600. The higher score indicates the worse quality of life.
5 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Social Functioning Scale
Time Frame: 10 minutes
Questionnaire is specifically designed to assess the most relevant areas of social functioning. The higher score indicates the better social function.
10 minutes
Depression scale
Time Frame: 5 minutes

The Beck Depression Inventory is a 21-item self-administered scale measuring various symptoms of depression. It comprises 21 groups of statements describing the somatic and cognitive-emotional symptoms of depression. Each item consists of four alternative responses.

graded from 0 to 3 according to the severity of the symptom. The patients choose the response closest to their state during the past week. A sum score is counted, a higher score indicating more severe depression
5 minutes
physical activity level
Time Frame: 5 minutes
Physical activity was assessed using the self-administered short (7-item) forms of the international physical activity questionnaire. The higher score indicates the more physically active lifestyle.
5 minutes
Musculoskeletal status
Time Frame: 5 minutes
The Nordic musculoskeletal questionnaire includes 27 items exploring the presence of musculoskeletal symptoms during a 12-month period covering the nine different parts of the body. The higher score indicates the worse musculoskeletal status.
5 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Hacettepe University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 30, 2019

Primary Completion (Actual)

June 1, 2020

Study Completion (Actual)

June 28, 2020

Study Registration Dates

First Submitted

November 13, 2019

First Submitted That Met QC Criteria

November 13, 2019

First Posted (Actual)

November 15, 2019

Study Record Updates

Last Update Posted (Actual)

June 30, 2020

Last Update Submitted That Met QC Criteria

June 29, 2020

Last Verified

June 1, 2020

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • GO 19/1046

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe